Apis Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-17,000
Closed -$1.63M 51
2020
Q4
$1.63M Buy
+17,000
New +$1.75M 1.57% 19
2019
Q3
$2.95M Buy
+50,000
New +$3.19M 4.62% 6

Other funds holding TNDM

Apis Capital Advisors's TNDM Position: Q1 2021 in Review

Apis Capital Advisors sold out of Tandem Diabetes Care (TNDM) in Q1 2021, closing a stake of 17,000 shares — an estimated $1.63M sold.

Apis Capital Advisors first reported a position in TNDM in Q3 2019 and held it in 2 quarters. The position peaked at $2.95M in Q3 2019. 290 funds tracked by Wall St. Rank hold TNDM as of Q1 2021.

  • Apis Capital Advisors reported no remaining Tandem Diabetes Care position as of Q1 2021 after selling out during the quarter.
  • Apis Capital Advisors sold 17,000 Tandem Diabetes Care shares in Q1 2021, an estimated $1.63M.
  • Apis Capital Advisors first reported a position in Tandem Diabetes Care in Q3 2019 and held it in 2 quarters.
  • Apis Capital Advisors's Tandem Diabetes Care position peaked at $2.95M in Q3 2019.
  • 290 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2021.

Based on Apis Capital Advisors's 13F filing for Q1 2021, filed 14 May 2021.